Hood River Capital Management’s Guardant Health GH Stock Holding History

Hood River Capital Management’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$209M	Buy	1,395,307 +85,242	+7%	+$9.27M	1.52%	14
2026 Q1	$121M	Buy	1,310,065 +331,550	+34%	+$33.3M	1.21%	17
2025 Q4	$99.9M	Buy	978,515 +721,622	+281%	+$64.6M	1.1%	26
2025 Q3	$16.1M	Buy	256,893 +11,192	+5%	+$609K	0.19%	109
2025 Q2	$12.8M	Buy	245,701 +9,637	+4%	+$430K	0.18%	109
2025 Q1	$10.1M	Buy	236,064 +35,107	+17%	+$1.51M	0.17%	103
2024 Q4	$6.14M	Buy	200,957 +11,079	+6%	+$312K	0.09%	121
2024 Q3	$4.36M	Buy	189,878 +43,152	+29%	+$1.22M	0.07%	125
2024 Q2	$4.24M	Buy	+146,726	New	+$3.42M	0.09%	119

Other funds holding GH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Hood River Capital Management's GH Position: Q2 2026 in Review

Hood River Capital Management increased its Guardant Health (GH) stake by 6.5% in Q2 2026, buying an estimated $9.27M and bringing the position to 1,395,307 shares worth $209M. The position accounts for 1.52% of the portfolio, ranked #14.

Hood River Capital Management first reported a position in GH in Q2 2024 and has held it in 9 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

Hood River Capital Management held 1,395,307 shares of Guardant Health worth $209M as of Q2 2026.
Hood River Capital Management bought 85,242 Guardant Health shares in Q2 2026, an estimated $9.27M.
Guardant Health made up 1.52% of Hood River Capital Management's portfolio in Q2 2026, its #14 holding.
Hood River Capital Management first reported a position in Guardant Health in Q2 2024 and has held it in 9 quarters since.
597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Hood River Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.